Pays: Afrique du Sud
Langue: anglais
Source: South African Health Products Regulatory Authority (SAHPRA)
Gulf
INDICATIONS [/za_1185.html#1] [/za_1185.html#1] [/za_1185.html#1] CONTRA-INDICATIONS [/za_1185.html#1] [/za_1185.html#1] DOSAGE [/za_1185.html#1] [/za_1185.html#1] SIDE-EFFECTS [/za_1185.html#1] [/za_1185.html#1] [/za_1185.html#1] PREGNANCY [/za_1185.html#1] [/za_1185.html#1] OVERDOSE [/za_1185.html#1] IDENTIFICATION [/za_1185.html#1] [/za_1185.html#1] PATIENT INFORMATION GULF INDOMETHACIN 25 SCHEDULING STATUS: S3 PROPRIETARY NAME (and dosage form): GULF INDOMETHACIN 25 COMPOSITION: Each GULF INDOMETHACIN 25 capsule contains 25 mg Indomethacin . PHARMACOLOGICAL CLASSIFICATION: A 3.1 Antirheumatics (Anti-inflammatory agents) PHARMACOLOGICAL ACTION: Indomethacin is a non-steroidal anti-inflammatory drug with anti-inflammatory and analgesic properties, which are mediated through its mode of action as an inhibitor of prostaglandin synthesis. INDICATIONS: Indomethacin is indicated for the symptomatic treatment of rheumatoid arthritis, ankylosing/spondylitis, osteoarthritis, other musculoskeletal inflammatory disorders and acute attacks of gout. CONTRA-INDICATIONS: GULF INDOMETHACIN 25 is contra-indicated in persons hypersensitive to it or to aspirin, persons operating machinery, or patients with psychiatric disorders, epilepsy or Parkinson’s. It is contra-indicated in persons with renal disease or ulcerative lesions of the stomach or intestines. GULF INDOMETHACIN 25 is also contra-indicated in patients with bleeding disorders, active peptic ulcers, gastritis, regional enteritis and ulcerative colitis, history of gastrointestinal bleeding or perforation (PUBs) related to previous NSAIDS, active or history of recurrent ulcer/haemorrhage/perforations, heart failure as well as in pregnant and nursing women and in children. WARNINGS: Serious interactions have been reported after the use of Lire le document complet